HS
Harold H. Shlevin

Harold H. Shlevin insider trades: Galectin Therapeutics (GALT) stock buys and sales

Galectin Therapeutics Last trade Jun 29, 2026 30 Form 4 filings
$1.6M
Sold, last 12 months
5 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2013
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Harold reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 29, 2026GALT↓ Sell$151K
Dec 17, 2025GALT↓ Sell$172K
Dec 15, 2025GALT↓ Sell$177K
Dec 9, 2025GALT↓ Sell$936K
Dec 8, 2025GALT↓ Sell$119K
Dec 30, 2024GALT↑ Buy$8K
Jun 13, 2018GALT↓ Sell$324K
Jun 11, 2018GALT↓ Sell$672K
Jun 7, 2018GALT↓ Sell$572K
Jun 5, 2018GALT↓ Sell$107K
Jun 1, 2018GALT↓ Sell$603K
Nov 18, 2013GALT↑ Buy$3K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other GALT insiders

Open-market trades in the last 12 months

About Harold H. Shlevin's insider trades

Harold H. Shlevin is an insider at Galectin Therapeutics (GALT). Since Nov 18, 2013, Harold has reported 2 open-market purchases worth $11K and 10 sales worth $3.8M on SEC Form 4. In the last 12 months: 5 sales ($1.6M).

Their filings also include grants and awards (16 filings), option exercises (12 filings), shares withheld for taxes (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GALT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.